These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21234716)

  • 21. Development of secondary sex characteristics in multitransfused thalassemic children.
    George A; Bhaduri A; Choudhry VP
    Indian J Pediatr; 1997; 64(6):855-9. PubMed ID: 10771930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of endocrine disorders in young children with multi-transfused thalassemia major.
    Mahmoud RA; Khodeary A; Farhan MS
    Ital J Pediatr; 2021 Jul; 47(1):165. PubMed ID: 34332621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine complications in transfusion dependent thalassaemia in Penang Hospital.
    Ong CK; Lim SL; Tan WC; Ong EE; Goh AS
    Med J Malaysia; 2008 Jun; 63(2):109-12. PubMed ID: 18942294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selected highlights of the VIII International Symposium of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A) on Growth, Puberty and Endocrine Complications in Thalassaemia. Auditorium of the Sultan Qaboos University (SQU) Muscat (Sultanate of Oman), 20th of December 2014.
    De Sanctis V; Soliman AT; Wali Y; Elsedfy H; Daar S; Al-Yaarubi SA; Mevada ST; Elshinawy M; Fawzy H; Al-Subhi T; Al-Rawas A; Al-Muslehi M; El Kholy M
    Pediatr Endocrinol Rev; 2015 Mar; 12(3):313-22. PubMed ID: 25962210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C.
    Pelletier F; Perrier S; Cayami FK; Mirchi A; Saikali S; Tran LT; Ulrick N; Guerrero K; Rampakakis E; van Spaendonk RML; Naidu S; Pohl D; Gibson WT; Demos M; Goizet C; Tejera-Martin I; Potic A; Fogel BL; Brais B; Sylvain M; Sébire G; Lourenço CM; Bonkowsky JL; Catsman-Berrevoets C; Pinto PS; Tirupathi S; Strømme P; de Grauw T; Gieruszczak-Bialek D; Krägeloh-Mann I; Mierzewska H; Philippi H; Rankin J; Atik T; Banwell B; Benko WS; Blaschek A; Bley A; Boltshauser E; Bratkovic D; Brozova K; Cimas I; Clough C; Corenblum B; Dinopoulos A; Dolan G; Faletra F; Fernandez R; Fletcher J; Garcia Garcia ME; Gasparini P; Gburek-Augustat J; Gonzalez Moron D; Hamati A; Harting I; Hertzberg C; Hill A; Hobson GM; Innes AM; Kauffman M; Kirwin SM; Kluger G; Kolditz P; Kotzaeridou U; La Piana R; Liston E; McClintock W; McEntagart M; McKenzie F; Melançon S; Misbahuddin A; Suri M; Monton FI; Moutton S; Murphy RPJ; Nickel M; Onay H; Orcesi S; Özkınay F; Patzer S; Pedro H; Pekic S; Pineda Marfa M; Pizzino A; Plecko B; Poll-The BT; Popovic V; Rating D; Rioux MF; Rodriguez Espinosa N; Ronan A; Ostergaard JR; Rossignol E; Sanchez-Carpintero R; Schossig A; Senbil N; Sønderberg Roos LK; Stevens CA; Synofzik M; Sztriha L; Tibussek D; Timmann D; Tonduti D; van de Warrenburg BP; Vázquez-López M; Venkateswaran S; Wasling P; Wassmer E; Webster RI; Wiegand G; Yoon G; Rotteveel J; Schiffmann R; van der Knaap MS; Vanderver A; Martos-Moreno GÁ; Polychronakos C; Wolf NI; Bernard G
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e660-e674. PubMed ID: 33005949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid function in thalassaemia major.
    Senanayake MP; Suraweera SA; Hubert HD
    Ceylon Med J; 1999 Dec; 44(4):166-8. PubMed ID: 10895267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Efficacy and Safety of Oral Iron Chelators and their Novel Combination in Children with Thalassemia.
    Gomber S; Jain P; Sharma S; Narang M
    Indian Pediatr; 2016 Mar; 53(3):207-10. PubMed ID: 27029681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine complications of thalassemia.
    Tiosano D; Hochberg Z
    J Endocrinol Invest; 2001 Oct; 24(9):716-23. PubMed ID: 11716158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term Assessment of HSCT Effects on the Hypothalamus-Pituitary Axis in Pediatric Thalassemic Patients.
    Hamidieh AA; Mohseni F; Behfar M; Hamidi Z; Alimoghaddam K; Pajouhi M; Larijani B; Mohajeri-Tehrani MR; Ghavamzadeh A
    Arch Iran Med; 2018 Feb; 21(2):56-60. PubMed ID: 29664655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study on endocrine dysfunction in thalassaemia.
    Ghosh S; Bandyopadhyay SK; Bandyopadhyay R; Roy D; Maisnam I; Ghosh MK
    J Indian Med Assoc; 2008 Oct; 106(10):655-6, 658-9. PubMed ID: 19552099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron Chelation Therapy as a Modality of Management.
    Aydinok Y
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):261-275. PubMed ID: 29458731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors associated with hypogonadism in β-thalassemia major patients: predictors for a frequent complication of a rare disease.
    Albu A; Barbu CG; Antonie L; Vladareanu F; Fica S
    Postgrad Med; 2014 Sep; 126(5):121-7. PubMed ID: 25295656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD).
    Yassin MA; Soliman AT; De Sanctis V; Abdula MAJ; Riaz LM; Ghori FF; Yousaf A; Nashwan AJ; Abusamaan S; Moustafa A; Kohla S; Soliman DS
    Acta Biomed; 2018 Feb; 89(2-S):33-40. PubMed ID: 29451227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with beta-thalassemia major.
    Soliman AT; Nasr I; Thabet A; Rizk MM; El Matary W
    Metabolism; 2005 Jan; 54(1):15-23. PubMed ID: 15562375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America.
    Vogiatzi MG; Macklin EA; Trachtenberg FL; Fung EB; Cheung AM; Vichinsky E; Olivieri N; Kirby M; Kwiatkowski JL; Cunningham M; Holm IA; Fleisher M; Grady RW; Peterson CM; Giardina PJ;
    Br J Haematol; 2009 Sep; 146(5):546-56. PubMed ID: 19604241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
    Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrinopathies in patients with transfusion-dependent beta-thalassemia.
    Mehrvar A; Azarkeivan A; Faranoush M; Mehrvar N; Saberinedjad J; Ghorbani R; Vossough P
    Pediatr Hematol Oncol; 2008; 25(3):187-94. PubMed ID: 18432501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of gonadal hormones in Egyptian female children with sickle cell anemia in correlation with iron overload: Single center study.
    Hagag AA; El-Farargy MS; Elrefaey S; Abo El-enein AM
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):1-7. PubMed ID: 26684919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Systematic Review and Meta-Analysis of Stature Growth Complications in β-thalassemia Major Patients.
    Arab-Zozani M; Kheyrandish S; Rastgar A; Miri-Moghaddam E
    Ann Glob Health; 2021 Jun; 87(1):48. PubMed ID: 34164261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.